Fulgent Corp (FLGT): Net earnings per share (EPS TTM)

Corporate emblem and logo of Fulgent Genetics (FLGT)

Fulgent Genetics, Inc. (FLGT) generates revenue based on the diagnosis of rare pathologies and cancer screening. The rolling annual EPS chart visualizes the dynamics of these processes, where the -3.11 mark characterizes this parameter. Efficiency is supported by AI-powered robotic sequencing, while turnaround time precision is ensured by a sophisticated courier delivery system for transporting biomaterials to central laboratories.

FLGT Fulgent Net earnings per share for the last four quarters (07/04/2022 - 11/15/2026)

Summary analytical data breakdowns for Fulgent (FLGT)

- current quotes and average value forecast:
Price Chart Fulgent Genetics Inc|FLGT - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Fulgent Genetics|FLGT - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Fulgent Genetics|FLGT - Book Valuation of Business|Market Capitalization to Book Value Ratio fulgentgenetics.com|FLGT - Total Asset Value of Company
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Fulgent Genetics, Inc.|FLGT - Long-Term Debt to Capital|Short-Term Debt to Equity Fulgent Genetics, Inc.|FLGT - Company Debts|Debts to Book Capitalization Fulgent Corp|FLGT - Long-Term Indebtedness|Company Short-Term Debts Fulgent Genetics|Quick Liquidity fulgentgenetics.com
- earnings and multiples data:
FLGT - Company Profit|Future Profit Fulgent Genetics, Inc.|FLGT - Market Price to Net Income Ratio|Projected Price to Earnings Fulgent Corp|FLGT - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Fulgent Corp|FLGT - Operating profit before depreciation charges|Net earnings per share (EPS TTM) Fulgent Genetics|FLGT - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months fulgentgenetics.com|FLGT - Earnings per share growth this year|Earnings growth forecast for next year Fulgent Genetics, Inc.
- total revenue and sales volume data:
FLGT - Company Total Revenue|Company Future Sales Volume Fulgent Genetics, Inc.|FLGT - Market Cap to Sales Volume|Forward P/S Multiple Fulgent Genetics
Fundamental company valuation:fulgentgenetics.com (FLGT)
Flagship merchandise of Fulgent Corp

The efficiency of Fulgent Genetics, Inc. (FLGT) in the DNA analysis and oncology screening segment directly determines the final net income allocated per share. By analyzing the annual EPS TTM snapshot on the GURU.Markets platform, an investor can observe the adjusted 12-month profit trend without quarterly lags, allowing for an objective assessment of the company's fundamental value and investment grade while eliminating emotional market distortions.

Analysis of competing companies

agilent.com - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Quest Diagnostics Inc. DGX|ILMN: Net earnings per share (EPS TTM)|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|LAB: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cytek Biosciences Inc (CTKB)|Net earnings per share for the last 12 months OSUR|Earnings per share for the last 12 months XGN (Exagen)|Net earnings per share (EPS TTM) MDXH|LUCD (Lucid Diagnostics Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRE (Prenetics Global)|Earnings per share for the last four quarters IMDX (imdxinc.com)|TRIB: Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months ProPhase Labs, Inc.|AIMD: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com (CODX)|Net earnings per share for the last 12 months HSCS|BMRA: Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO|Net earnings per share for the last four quarters Onconetix Corporation|Net earnings per share (EPS TTM) VRAX (Virax Biolabs Group)|Net earnings per share for the trailing year bluejaydx.com|AWH: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Accelerate Diagnostics, Inc. AXDX|CNTG (CENTOGENE) - Net earnings per share for the last 12 months|Earnings per share for the last 12 months ENZ|FRES: Net earnings per share for the last four quarters|Earnings per share for the last twelve months GENE|Net earnings per share for the last 12 months ME (23andMe Holding Co)|PMD - Net earnings per one share for the last twelve months